Form 4: ClearPoint Neuro Director Timothy T. Richards Acquires Shares in Lieu of Fees
SEC Form 4 Filing
Director Timothy T. Richards acquired 1,640 shares of ClearPoint Neuro, Inc. common stock on April 1, 2024, as payment for fees under the company's Non-Employee Director Compensation Plan.
Summary
- On April 1, 2024, Timothy T. Richards, a director of ClearPoint Neuro, Inc., acquired 1,640 shares of common stock.
- The acquisition was made as payment for fees owed to Richards under the company's Non-Employee Director Compensation Plan.
- The shares were issued at a price of $6.80, which was the closing price of ClearPoint Neuro's common stock on March 28, 2024.
- Following the transaction, Richards directly owns 44,408 shares of ClearPoint Neuro, Inc.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. A director taking shares in lieu of cash compensation is generally a good sign, indicating confidence in the company's future and conserving cash.
Positives
- The acquisition of shares by a director demonstrates confidence in the company.
- Using stock to pay director fees conserves cash for the company.
Industry Context
Director share acquisitions are common in the biotech industry as a form of compensation and alignment of interests.
Comparison to Industry Standards
- Many companies in the biotech sector, such as Neurocrine Biosciences and Global Blood Therapeutics, use equity-based compensation for their directors.
- The amount of equity granted to directors varies based on company size, performance, and industry norms.
- ClearPoint Neuro's approach aligns with industry practices of using stock to compensate directors, conserving cash and aligning director interests with shareholder value.
Related Party Transactions
- The issuance of shares to Timothy T. Richards, a director, is a related party transaction.
Stakeholder Impact
- Shareholders may view the director's share acquisition positively, as it aligns the director's interests with theirs.
- The company benefits from conserving cash by using stock for compensation.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Date used to determine the share price for the transaction ($6.80 closing price). |
| 04/01/2024 | Date of the transaction where Timothy T. Richards acquired shares. |
| 04/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.